PrEP is one of the most powerful tools in HIV prevention. Yet for many Black LGBTQ+ people, getting access to the medication is far harder than it should be.
Discover how UCSF is leading the charge in Long COVID research, uncovering key findings that advance our understanding of the ...
Godfrey Dzhivhuho has dedicated his career to understanding HIV and other infectious diseases, inspired by the epidemic he witnessed growing up. Raised in Warrenton-Kimberly, South Africa, the oldest ...
You may not realize you’ve benefited from HIV research. But if you’ve received a treatment that was approved through a recent clinical trial, received a CAR T cell for your cancer, or even just taken ...
Scientists say research into a vaccine for HIV is further along than it’s ever been. But Trump administration cuts to scientific research have set that effort back. Including a promising trial for an ...
University of Virginia School of Medicine scientists have uncovered a key reason why HIV remains so difficult to cure, bringing researchers closer to finding ways to flush out the dormant virus and ...
Gilead Sciences' new shot is a drug named lenacapavir, which was tested in two studies and reportedly eliminated HIV infections in high-risk patients. People have to test negative for HIV before they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results